Sintesi Research
Private Company
Funding information not available
Overview
Sintesi Research is a private, Milan-based Contract Research Organization (CRO) established in 2006. It provides clinical research services to biotech and pharma clients, emphasizing quality, attention to detail, and on-time, on-budget project execution. The company leverages expertise in drug delivery and small molecules to support client programs, positioning itself as a trusted partner in the drug development process. Its business model is service-based, generating revenue through contracted research work.
Technology Platform
Integrated CRO services specializing in drug delivery technologies and small molecule pharmaceutical development, including formulation, analytical development, and clinical research operations.
Opportunities
Risk Factors
Competitive Landscape
Sintesi competes in the fragmented global CRO market, facing large, full-service firms (e.g., IQVIA, ICON) and many smaller, specialized service providers. Its differentiation is based on deep expertise in drug delivery and small molecules, a quality-focused client approach, and its European base. Competition is based on scientific reputation, cost, and service reliability.